Search for: "Eli Lilly " Results 521 - 540 of 2,147
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 Oct 2016, 6:52 am
A wife complaints to the Qadi about her husband's impotence Artist: Hamse-i Atai (18th century Ottoman miniature) Source Wikipedia Mr Justice Birss: Actavis and Others v Eli Lilly and Another [2016] EWHC 1955 (Pat) (10 Aug 2016)  Although it is not spelt out anywhere in the 492 paragraphs and annexes to Mr Justice Birss's judgment, this complicated [read post]
18 Feb 2008, 10:06 am
New claims against Eli Lilly Co. over harmful side effects of the defective drug Zyprexa have now brought the total number of drug settlements to over 25,000. 900 new cases, including 5 that were set to go to trial in February, were settled recently, leaving the total number of unsettled cases at 1,100. [read post]
26 Aug 2014, 11:44 am by Pete Strom
28 Plaintiffs in Cymbalta MDL May Get Moved to California A multidistrict litigation (MDL) against Cymbalta, from pharmaceutical manufacturer Eli Lilly, claims that plaintiffs faced serious withdrawal symptoms when they stopped taking the antidepressant, including “brain zaps” and other debilitating health problems. [read post]
21 Nov 2023, 12:53 pm by Rick Hasen
Release: Pharmaceutical Research and Manufacturers of America — the trade association also known as PhRMA that represents the country’s top drug companies, including Eli Lilly, Merck, and Pfizer — has contributed more than $34.5 million to the Republican-aligned dark money… Continue reading The post “PhRMA contributed record sum to GOP-aligned dark money group in 2022, new tax filing reviewed by Issue One shows” appeared first on Election Law… [read post]
9 Dec 2021, 11:02 am by Tom Lamb
As we wrote about in this recent article, "Eli Lilly Attempts to Distance Olumiant From the Ominous JAK Inhibitors Drug Class Safety Issues Flagged by FDA", the pharmaceutical companies AbbieVie and Eli Lilly have attempted to distinguish the safety profile of their respective JAK inhibitors drug product from the various adverse drug reactions that have been observed in the Xeljanz clinical trial that have driven the FDA regulatory actions driving these… [read post]
2 Feb 2015, 5:58 am
Indianapolis, Indiana - An Indiana patent attorney for Eli Lilly and Company ("Lilly") of Indianapolis, Indiana filed an intellectual property lawsuit in the Southern District of Indiana alleging that Fresenius Kabi USA, LLC ("Fresenius") of Lake Zurich, Illinois infringed the patented product ALIMTA®, Patent No. 7,772,209, which has been registered by the U.S. [read post]
18 Dec 2014, 9:30 pm by Patent Docs
Eli Lilly and Company v. [read post]
13 Oct 2008, 2:41 pm
Hot off the press comes the ruling today of Mr Justice Floyd (Patents Court, England and Wales) in Dr Reddy's Laboratories (UK) Ltd v Eli Lilly and Company Ltd [2008] EWHC 2345 (Pat). [read post]
6 Dec 2009, 9:55 pm
While most of these companies have taken positions supportive of Lilly on the question of the existence of a separate written description requirement, one company (Novozymes) supports Ariad's position and another... [read post]
21 Sep 2009, 2:30 am
Patent holder Eli Lilly and Company has claimed infringement by Sandoz, Inc. and others. [read post]
13 Oct 2008, 6:55 pm
Major drug company settled for big cash and agreed to change some of its practices after questions were raised about its top-selling anti-psychotic drug. [read post]
21 Nov 2018, 12:00 am by Alexa von Uexküll
Alexa von Uexküll and Oswin RidderbuschOver the past few years the pan-European and parallel national patent litigation based on Eli Lilly’s pemetrexed patent has attracted considerable attention, as it has resulted in a number of diverse land mark decisions in relation to the doctrine of equivalence, as evidenced by the various posts in this blog. [read post]
4 Jun 2009, 9:56 pm
Eli Lilly), Judge Rader's decision confirms that the written description requirement is particularly relevant to the essential interference question of inventive priority. [read post]